These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cutaneous Manifestation of Drug Allergy and Hypersensitivity. Zalewska-Janowska A; Spiewak R; Kowalski ML Immunol Allergy Clin North Am; 2017 Feb; 37(1):165-181. PubMed ID: 27886905 [TBL] [Abstract][Full Text] [Related]
11. The role of reactive drug metabolites in immune-mediated adverse drug reactions. Hess DA; Rieder MJ Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694 [TBL] [Abstract][Full Text] [Related]
12. Ten Weeks of Infection with a Tissue-Invasive Helminth Protects against Local Immune Complex-Mediated Inflammation, but Not Cutaneous Type I Hypersensitivity, in Previously Sensitized Mice. Evans H; Killoran KE; Mitre BK; Morris CP; Kim SY; Mitre E J Immunol; 2015 Oct; 195(7):2973-84. PubMed ID: 26324775 [TBL] [Abstract][Full Text] [Related]
13. The Value of In Vitro Tests to DiminishDrug Challenges. Mayorga C; Doña I; Perez-Inestrosa E; Fernández TD; Torres MJ Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590437 [TBL] [Abstract][Full Text] [Related]
15. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B. Kim JT; Jeong HW; Choi KH; Yoon TY; Sung N; Choi YK; Kim EH; Chae HB World J Gastroenterol; 2014 Nov; 20(42):15931-6. PubMed ID: 25400481 [TBL] [Abstract][Full Text] [Related]
16. The innate immune system in delayed cutaneous allergic reactions to medications. Bellón T; Blanca M Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):292-8. PubMed ID: 21659858 [TBL] [Abstract][Full Text] [Related]